12:00 AM
 | 
Sep 15, 2014
 |  BC Week In Review  |  Clinical News  |  Regulatory

Afluria regulatory update

CSL's bioCSL Inc. (formerly CSL Biotherapies) subsidiary and PharmaJet Inc. (Golden, Colo.) said FDA approved the PharmaJet Stratis 0.5 mL...

Read the full 86 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >